UBS AM’s Apyx Medical APYX Stock Holding History

UBS AM’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-25,007	Closed	-$96K	–	2556
2014 Q1	$96K	Buy	+25,007	New	+$73.6K	﹤0.01%	2548

Other funds holding APYX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

MIAN

Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

UBS AM's APYX Position: Q2 2014 in Review

UBS AM sold out of Apyx Medical (APYX) in Q2 2014, closing a stake of 25,007 shares — an estimated $96K sold.

UBS AM first reported a position in APYX in Q1 2014 and held it in 1 quarter. The position peaked at $96K in Q1 2014. 23 funds tracked by Wall St. Rank hold APYX as of Q2 2014.

UBS AM reported no remaining Apyx Medical position as of Q2 2014 after selling out during the quarter.
UBS AM sold 25,007 Apyx Medical shares in Q2 2014, an estimated $96K.
UBS AM first reported a position in Apyx Medical in Q1 2014 and held it in 1 quarter.
UBS AM's Apyx Medical position peaked at $96K in Q1 2014.
23 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2014.

Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.